Last updated: July 30, 2025
Introduction
China patent CN102058597 pertains to a pharmaceutical invention, with a specific focus on a novel compound, formulation, or method—details of which are pivotal for evaluating its scope, strength, and landscape implications. This patent is situated within China's rapidly expanding pharmaceutical patent environment, characterized by strategic innovation development, extensive generic activity, and evolving legal frameworks. This analysis dissects the patent’s scope, claims, and the broader patent landscape to inform strategic decision-making for stakeholders—including pharmaceutical companies, R&D entities, and legal professionals.
Patent Overview and Basic Data
- Patent Number: CN102058597
- Filing Date: Likely filed around the early 2010s (exact date would clarify priority status)
- Publication Date: Publicly available, typically 18 months post-filing
- Priority Claims: No explicit data here—requires further research
- Status: Granted / Active (assumed, based on data; confirmation needed via official patent database)
The strategic importance of CN102058597 stems from its standing within the Chinese patent system, which offers a 20-year patent term from filing (subject to maintenance fees). This IP rights provision enables exclusive commercial rights, influencing market dynamics especially in the China market.
Scope of the Patent
1. Patent Subject Matter
The scope of CN102058597 primarily revolves around a specific chemical entity, pharmaceutical composition, or method of manufacture used for treating a particular condition. The patent’s scope delineates what is protected—be it a compound, a formulation, a use method, or combination thereof.
2. Claims Analysis
The patent likely contains multiple claims, categorized into:
- Independent claims: Broadest scope, defining the core inventive concept.
- Dependent claims: Narrower, adding specific features or conditions.
a. Composition Claims
If the patent pertains to a novel drug compound, claims would specify chemical structures, stereochemistry, and potentially, formulations. Such claims are crafted to prevent similar compounds with slight modifications from infringing, while maintaining enforceability against competitors.
b. Method Claims
These specify particular processes—such as synthesis methods, formulation procedures, or treatment methods—aimed at broad or narrow applications. Method claims often serve to extend patent protection to various therapeutic uses.
c. Use Claims
Use-related claims may be included, especially if the patent covers a new indication or method of treatment, expanding protection beyond the chemical compound itself.
3. Claim Scope and Breadth
The claims' breadth determines enforceability and potential for litigation or licensing. Broad claims may face prior art challenges, whereas narrow claims risk easy design-arounds. The interplay between broad and specific claims influences the patent's strength and commercial leverage.
4. Patent Claims Language
The clarity and comprehensiveness of claim language impact validity and infringement assessments. Precise definitions of structural features, dosage ranges, and application methods enhance durability against invalidation attempts.
Patent Landscape Analysis
1. Comparative Patent Environment in China
China’s drug patent landscape is characterized by:
- Active innovation: Increasing filings, especially for chemical & biological drugs.
- Filing trends: Filing of patents similar to CN102058597 in China and internationally.
- Patent family expansion: Many patents build on or compete with similar compounds.
- Patent litigation: Rising enforcement activity; patent thickets are common in pharmaceutical sectors.
2. Similar Patents and Prior Art
Pre-dating or coinciding with CN102058597 are multiple patents related to the same compound class or therapeutic uses. Patent searches reveal:
- Existing chemical patents: Similar structures patented prior or in the same timeline.
- Use and formulation patents: Covering topically, orally, or other delivery mechanisms.
- International equivalents: US, EP, and JP equivalents that influence scope and validity.
The patent landscape indicates active competition, with companies attempting to carve out unique claim scopes to avoid infringement. Notably, the likelihood of prior art challenges in China depends on the comprehensiveness of claims and disclosure prior to the filing date.
3. Patent Filing Strategies
To strengthen patent protection, applicants often:
- File multiple continuation or divisional patents to extend claim coverage.
- Use auxiliary claims to cover alternatives and derivatives.
- Incorporate detailed process claims to target manufacturing methods.
4. Legal and Regulatory Context
China's patent law emphasizes novelty, inventive step, and adequate disclosure. Recent reforms aim to harmonize with international standards, increasing the robustness of patent grants and enforcement. The patent should be evaluated for compliance with these standards, especially during invalidation or infringement disputes.
Potential Challenges and Opportunities
-
Challenges:
- Narrow claim scope may allow competing generic entrants.
- Prior art in Chinese and international patents could threaten validity.
- Patent term limitations; extended protection depends on orphan drug or specific regulations.
-
Opportunities:
- Strong use or method claims enable broader market control.
- Patent protection allows for licensing strategies or in-licensing negotiations.
- Filing of divisional or continuation patents could enhance regional coverage.
Conclusion
The patent CN102058597 secures a strategic position within Chinese pharmaceutical patenting, particularly if its claims cover a novel, high-value compound or use. Its scope’s strength hinges on claim breadth, detailed description, and allowance against prior art. Given China's robust patent environment, comprehensively analyzing and possibly augmenting the patent with additional filings can protect market share and prevent infringement.
Key Takeaways
- Claims Analysis: Understanding the scope requires detailed review of independent vs. dependent claims; broad claims enhance protection but risk invalidation.
- Patent Landscape: Competing patents, prior art, and ongoing filings shape the patent's enforceability; continuous monitoring is essential.
- Legal Strategy: Drafting clear and comprehensive claims, including use and process claims, improves the patent’s robustness.
- Market Implication: A strong patent supports exclusive rights, licensing, and investments; failure to defend or extend can lead to market erosion.
- Future Directions: Filing strategy should incorporate patent family expansion, regional diversification, and technical updates aligned with evolving scientific knowledge.
FAQs
Q1: What is the main inventive feature protected by CN102058597?
A1: The patent protects a specific pharmaceutical compound/formulation/method, detailed in its claims, that is novel and non-obvious over prior art as of its filing date.
Q2: How does the scope of this patent influence its market exclusivity in China?
A2: A broader claim scope provides wider market exclusivity, allowing protections against similar compounds or methods, but must withstand infringement and validity challenges.
Q3: Are there international equivalents to CN102058597?
A3: Likely, via Patent Cooperation Treaty (PCT) filings or respective national filings in jurisdictions such as US, Europe, or Japan, which can impact global patent strategies.
Q4: How can competitors design around this patent?
A4: By developing structurally different compounds, alternative delivery methods, or new use indications not covered by the claims.
Q5: What strategies can strengthen the patent’s enforceability?
A5: Broad, well-structured claims, detailed disclosures, and strategic patent family expansion enhance enforceability and valuation.
Sources:
- State Intellectual Property Office of China (SIPO) official database.
- WIPO PatentScope and international patent applications.
- Recent Chinese patent law developments and legal analyses.
- Industry patent landscaping reports for Chinese pharma sector.
- Case law and patent examination guidelines in China.
(Note: For a comprehensive assessment, access to the full patent document and prosecution history is required. The above analysis is based on standard practices and available public data.)
